Prodrugs of CL316243: a selective beta3-adrenergic receptor agonist for treating obesity and diabetes (Q78139137)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10450954%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

title

Prodrugs of CL316243: a selective beta3-adrenergic receptor agonist for treating obesity and diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10450954%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

author name string

F W Sum

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10450954%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

A Gilbert

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10450954%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

A M Venkatesan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10450954%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

K Lim

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10450954%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

V Wong

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10450954%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

M O'Dell

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10450954%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

G Francisco

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10450954%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Z Chen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10450954%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

G Grosu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10450954%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

J Baker

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10450954%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

J Ellingboe

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10450954%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

M Malamas

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10450954%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

I Gunawan

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10450954%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

J Primeau

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10450954%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

E Largis

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10450954%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

K Steiner

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10450954%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

publication date

1 July 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10450954%20AND%20SRC:MED&resulttype=core&format=json

Bioorganic & Medicinal Chemistry Letters

11 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10450954%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10450954%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

issue

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10450954%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

page(s)

1921-1926

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10450954%20AND%20SRC:MED&resulttype=core&format=json

Beta 3 and atypical beta-adrenoceptors

11 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900316-9

7 January 2021

Pharmacological treatment of obesity: therapeutic strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900316-9

7 January 2021

Pharmacological characteristics and species-related variations of beta 3-adrenergic receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900316-9

7 January 2021

Disodium (R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]-amino] propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316,243). A potent beta-adrenergic agonist virtually specific for beta 3 receptors. A promising antidiabetic and antiobesity agent

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900316-9

7 January 2021

Preparation of 1-acyloxyethyl esters of 7-[2-(2-aminothiazol-4-yl)acetamido]-3-[[[1-(2-dimethylaminoe thy l)-1H-tetrazol-5-yl]thio]-methyl]ceph-3-em-4-carboxylic acid (cefotiam) and their oral absorption in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900316-9

7 January 2021

10.1016/S0960-894X(99)00316-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10450954%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

1 reference